ELANIX BIOTECHNOLOGIES AG Elanix Biotechnologies AG
Elanix Biotechnologies AG
WKN: AOWMJQ ISIN: DEOOOAOWMJQ4 Land: Deutschland Nachricht vom 16.02.2017 I17:00
Elanix Biotechnologies AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Elanix Biotechnologies AG
16.02.2017 I 17:00
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
Details of issuer Elanix Biotechnologies AG Domstr. 22
14482 Potsdam
Germany
Reason for notification
x
Acauisition/dispos al of shares with voting rights
Acauisition/dispos al of instruments
Change of breakdown of voting rights
Other reason:
Details of person subject to the notification obligation Name: Cit and countr of re istered office :
Mr Gilbert Schoni
Names of shareholder(a)
holdin directly 3% or more voting rights, if different from 3.
Date on which threshold was crossed or reached
!10 Feb 2017
Total positions
% of voting rights attached to shares
(total of 7 .a.)
% of voting rights through instruments
(total of 7.b.1 +
7.b.2)
total of both in %
(7.a. +
7.b.)
total number of voting rights of issuer
Resulting situation
9.16 %
0.00 %
9.16 %
5666000
Previous
notification
12.37 %
0.00 %
12.37 %
I
Notified details of the resulting situation
Voting rights attached to shares (Sac.a 21, 22 WpHG)
ISIN
abso
lute
in %
direct (Sec. 21 WpHG)
indirect (Sec. 22 WpHG)
direct (Sec. 21 WpHG)
indirect (Sec. 22 WpHG)
DEOOOAOWMJQ4
519272
0
9.16 %
0.00 %
Total
519272
9.16 %
l.Instruments according to Sec. 25 para.1 No.1 WpHG
Type of
instrument
Expiration or maturity
date
Exercise or conversion
period
Voting rights
absolute
Voting rights
in %
ITotal I
b.2.Instruments according to Sec. 25 para.1 No.2 WpBG
Type of instrument
Expiration or maturity date
Exercise or conversion period
Cash or physical settlement
Voting rights
absolute
Voting rights in %
%
Total
%
Information in relation to the person subject to the notification obligation
x
Person subject to the notification obligation is not controlled and does itself not control any other undertaking( s) holding directly or indirectly an interest in the {underlying ) issuer
(1.) .
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name
% of voting rights (if at least held 3% or more)
% of voting rights through instruments (if at least held 5% or more)
Total of both (if at least held 5% or more)
In case of proxy voting according to Sac. 22 para.3 WpHG
Date of general meeting:
Holdin osition after eneral meetin % (e
Other explanatory remarks:
16.02.2017 The DGAP Distribution Services include Regulatory Announcements , Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: Company:
English
Elanix Biotechnologies AG Domstr. 22
14482 Potsdam Germany
End of News DGAP News Service
DGAP -ein Service der EQS Group AG
Twitter Ilmpressum IAGB IRechtlche Hinweise & Datenschutz
Elanix Biotechnologies AG published this content on 16 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 17 February 2017 08:53:05 UTC.
Original documenthttps://elanixbiotechnologies.com/wp-content/uploads/2017/02/Release-according-to-Article-26-Section-1-of-the-WpHG-the-German-Securities-Trading-Act-with-the-objective-of-Europe-wide-distribution.pdf
Public permalinkhttp://www.publicnow.com/view/2E4BCDDBAD18ABBE7DF7A438318158BB073C2864
